Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 3 of 3

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

The impact of changes at the vireoretinal interface and retinal thickness following the administration of a single 0.19 mg fluocinolone acetonide (FAc, ILUVIEN) device, implanted after partial PPV in patients with persistent or recurrent DME – results from the ILUVIT study, a single center, phase IV study.

Frank H J Koch; Pankaj Singh; Adonis Chedid; Natallia Brui; Thomas Kohnen; Hanns Ackermann; Svenja Deuchler

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4870.

ARVO Annual Meeting Abstract June 2020

Reduced vitreous cytokine levels following the administration of a single 0.19 mg fluocinolone acetonide (FAc, ILUVIEN) implant in patients with persistent or recurrent DME – results from the ILUVIT study.

Svenja Deuchler; Pankaj Singh; Adonis Chedid; Natallia Brui; Thomas Kohnen; Hanns Ackermann; Frank H J Koch

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4873.

ARVO Annual Meeting Abstract June 2020

The correlation between the expression of cytokines and growth factors and the clinical stage of diabetic retinopathy in patients with DME – results from the ILUVIT study, a single center, phase IV study.

Pankaj Singh; Svenja Deuchler; Adonis Chedid; Natallia Brui; Thomas Kohnen; Hanns Ackermann; Frank H J Koch

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4879.

Advertisement